These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 34508903

  • 21. The effect of vitamin D treatment on clinical and biochemical outcomes of primary aldosteronism.
    Ismail NA, Kamaruddin NA, Azhar Shah S, Sukor N.
    Clin Endocrinol (Oxf); 2020 Jun; 92(6):509-517. PubMed ID: 32073675
    [Abstract] [Full Text] [Related]

  • 22. Vitamin D, parathyroid hormone levels and bone mineral density in community-dwelling older women: the Rancho Bernardo Study.
    von Mühlen DG, Greendale GA, Garland CF, Wan L, Barrett-Connor E.
    Osteoporos Int; 2005 Dec; 16(12):1721-6. PubMed ID: 15928802
    [Abstract] [Full Text] [Related]

  • 23. Bone and mineral metabolism in patients with primary aldosteronism.
    Petramala L, Zinnamosca L, Settevendemmie A, Marinelli C, Nardi M, Concistrè A, Corpaci F, Tonnarini G, De Toma G, Letizia C.
    Int J Endocrinol; 2014 Dec; 2014():836529. PubMed ID: 24864141
    [Abstract] [Full Text] [Related]

  • 24. Parathyroid hormone, aldosterone-to-renin ratio and fibroblast growth factor-23 as determinants of nocturnal blood pressure in primary hyperparathyroidism: the eplerenone in primary hyperparathyroidism trial.
    Verheyen N, Fahrleitner-Pammer A, Pieske B, Meinitzer A, Belyavskiy E, Wetzel J, Gaksch M, Grübler MR, Catena C, Sechi LA, Van Ballegooijen AJ, Brandenburg VM, Scharnagl H, Perl S, Brussee H, März W, Pilz S, Tomaschitz A.
    J Hypertens; 2016 Sep; 34(9):1778-86. PubMed ID: 27379537
    [Abstract] [Full Text] [Related]

  • 25. Correlations between vitamin D status and biochemical/clinical and pathological parameters in primary hyperparathyroidism.
    Ozbey N, Erbil Y, Ademoğlu E, Ozarmağan S, Barbaros U, Bozbora A.
    World J Surg; 2006 Mar; 30(3):321-6. PubMed ID: 16467981
    [Abstract] [Full Text] [Related]

  • 26. Bone and mineral metabolism in patients with primary aldosteronism: A systematic review and meta-analysis.
    Wang A, Wang Y, Liu H, Hu X, Li J, Xu H, Nie Z, Zhang L, Lyu Z.
    Front Endocrinol (Lausanne); 2022 Mar; 13():1027841. PubMed ID: 36387892
    [Abstract] [Full Text] [Related]

  • 27. Vitamin D deficiency, parathyroid hormone levels, and bone disease among patients with end-stage liver disease and normal serum creatinine awaiting liver transplantation.
    Corey RL, Whitaker MD, Crowell MD, Keddis MT, Aqel B, Balan V, Byrne T, Carey E, Douglas DD, Harrison ME, Vargas HE, Rakela J.
    Clin Transplant; 2014 May; 28(5):579-84. PubMed ID: 24628047
    [Abstract] [Full Text] [Related]

  • 28. [Value of serum parathyroid hormone in the diagnosis of primary aldosteronism].
    Liu YJ, Yang GQ, Pei JT, Dou ZH, Lyu J, Du JM, Ba YM, Mu Y.
    Zhonghua Yi Xue Za Zhi; 2021 Sep 14; 101(34):2674-2680. PubMed ID: 34510873
    [Abstract] [Full Text] [Related]

  • 29. [Diagnosis and treatment outcome in primary aldosteronism based on a retrospective analysis of 187 cases].
    Szücs N, Gláz E, Varga I, Tóth M, Kiss R, Patócs A, Jakab C, Perner F, Járay J, Horányi J, Dabasi G, Molnár F, Major L, Füto L, Rácz K, Tulassay Z.
    Orv Hetil; 2006 Jan 15; 147(2):51-9. PubMed ID: 16509213
    [Abstract] [Full Text] [Related]

  • 30. Serum aldosterone is correlated positively to parathyroid hormone (PTH) levels in patients with primary hyperparathyroidism.
    Brunaud L, Germain A, Zarnegar R, Rancier M, Alrasheedi S, Caillard C, Ayav A, Weryha G, Mirallie E, Bresler L.
    Surgery; 2009 Dec 15; 146(6):1035-41. PubMed ID: 19958930
    [Abstract] [Full Text] [Related]

  • 31. Serum 25-hydroxyvitamin D, parathyroid hormone, calcium intake, and bone mineral density in Spanish adults.
    Olmos JM, Hernández JL, García-Velasco P, Martínez J, Llorca J, González-Macías J.
    Osteoporos Int; 2016 Jan 15; 27(1):105-13. PubMed ID: 26134682
    [Abstract] [Full Text] [Related]

  • 32. Role of 1,25-dihydroxy vitamin D3 and parathyroid hormone in urinary calcium excretion in calcium stone formers.
    Kim WT, Kim YJ, Yun SJ, Shin KS, Choi YD, Lee SC, Kim WJ.
    Yonsei Med J; 2014 Sep 15; 55(5):1326-32. PubMed ID: 25048492
    [Abstract] [Full Text] [Related]

  • 33. Plasma 25-hydroxyvitamin D and not 1,25-dihydroxyvitamin D is associated with parathyroid adenoma secretion in primary hyperparathyroidism: a cross-sectional study.
    Moosgaard B, Vestergaard P, Heickendorff L, Melsen F, Christiansen P, Mosekilde L.
    Eur J Endocrinol; 2006 Aug 15; 155(2):237-44. PubMed ID: 16868136
    [Abstract] [Full Text] [Related]

  • 34. PTH Is a Promising Auxiliary Index for the Clinical Diagnosis of Aldosterone-Producing Adenoma.
    Zhang LX, Gu WJ, Li YJ, Wang Y, Wang WB, Wang AP, Shen L, Zang L, Yang GQ, Lu ZH, Dou JT, Mu YM.
    Am J Hypertens; 2016 May 15; 29(5):575-81. PubMed ID: 26304960
    [Abstract] [Full Text] [Related]

  • 35. Primary Aldosteronism and Bone Metabolism: A Systematic Review and Meta-Analysis.
    Shi S, Lu C, Tian H, Ren Y, Chen T.
    Front Endocrinol (Lausanne); 2020 May 15; 11():574151. PubMed ID: 33101208
    [Abstract] [Full Text] [Related]

  • 36. Effects of oral phosphorus supplementation on mineral metabolism of renal transplant recipients.
    Caravaca F, Fernández MA, Ruiz-Calero R, Cubero J, Aparicio A, Jimenez F, García MC.
    Nephrol Dial Transplant; 1998 Oct 15; 13(10):2605-11. PubMed ID: 9794568
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. IDENTIFYING PARATHYROID HORMONE DISORDERS AND THEIR PHENOTYPES THROUGH A BONE HEALTH SCREENING PANEL: IT'S NOT SIMPLE VITAMIN D DEFICIENCY!
    Majid H, Khan AH, Riaz M, Karimi H, Talati J.
    Endocr Pract; 2016 Jul 15; 22(7):814-21. PubMed ID: 27018622
    [Abstract] [Full Text] [Related]

  • 39. Impact of vitamin D-related serum PTH reference values on the diagnosis of mild primary hyperparathyroidism, using bivariate calcium/PTH reference regions.
    Fillée C, Keller T, Mourad M, Brinkmann T, Ketelslegers JM.
    Clin Endocrinol (Oxf); 2012 Jun 15; 76(6):785-9. PubMed ID: 22066864
    [Abstract] [Full Text] [Related]

  • 40. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V, Torregrosa V.
    Nefrologia; 2008 Jun 15; 28 Suppl 3():67-78. PubMed ID: 19018742
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.